BR112013003127A2 - bismuto-tióis como antissépticos para usos agrícolas, industriais e outros - Google Patents

bismuto-tióis como antissépticos para usos agrícolas, industriais e outros

Info

Publication number
BR112013003127A2
BR112013003127A2 BR112013003127A BR112013003127A BR112013003127A2 BR 112013003127 A2 BR112013003127 A2 BR 112013003127A2 BR 112013003127 A BR112013003127 A BR 112013003127A BR 112013003127 A BR112013003127 A BR 112013003127A BR 112013003127 A2 BR112013003127 A2 BR 112013003127A2
Authority
BR
Brazil
Prior art keywords
compositions
bismuththiols
antiseptics
agricultural
industrial
Prior art date
Application number
BR112013003127A
Other languages
English (en)
Inventor
Brett Hugh James Baker
Original Assignee
Microbion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/023549 external-priority patent/WO2011097347A2/en
Application filed by Microbion Corp filed Critical Microbion Corp
Publication of BR112013003127A2 publication Critical patent/BR112013003127A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

bismuto-tióis como antissépticos para usos agrícolas, industriais e outros. composições e métodos, incluindo novas suspensões de microparticulados homogêneas, são descritos para tratar superfícies naturais e artificiais que contêm biopelícula bacteriana, incluindo efeitos de sinergia ou realce inesperados entre os compostos de bismuto-tiol (bt) e certos antibióticos, para fornecer formulações, incluindo formulações antissépticas. propriedades antibacterianas e propriedades antiopelícula previamente inesperadas de compostos de bt e combinações de composto de bt mais antibiótico divulgadas também são descritas, incluindo eficácias preferenciais de tais composições para tratar certa infecções bacterianas gram-positivais, e eficácias preferenciais distintas de tais composições para tratar certas infecções bacterianas gram-negativas.
BR112013003127A 2010-08-12 2011-08-11 bismuto-tióis como antissépticos para usos agrícolas, industriais e outros BR112013003127A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37318810P 2010-08-12 2010-08-12
PCT/US2011/023549 WO2011097347A2 (en) 2010-02-03 2011-02-03 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
PCT/US2011/047490 WO2012021754A2 (en) 2010-08-12 2011-08-11 Bismuth-thiols as antiseptics for agricultural, industrial and other uses

Publications (1)

Publication Number Publication Date
BR112013003127A2 true BR112013003127A2 (pt) 2016-06-28

Family

ID=44356067

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112012019286A BR112012019286A2 (pt) 2010-02-03 2011-02-03 bismuto-tióis como antisséptico para usos biomédicos, que incluem tratamento de biofilmes bacterianos e outros usos
BR112013003127A BR112013003127A2 (pt) 2010-08-12 2011-08-11 bismuto-tióis como antissépticos para usos agrícolas, industriais e outros

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112012019286A BR112012019286A2 (pt) 2010-02-03 2011-02-03 bismuto-tióis como antisséptico para usos biomédicos, que incluem tratamento de biofilmes bacterianos e outros usos

Country Status (16)

Country Link
EP (1) EP2603083A4 (pt)
JP (7) JP2013535506A (pt)
KR (6) KR20200015814A (pt)
CN (2) CN103096720B (pt)
AU (3) AU2011289338B2 (pt)
BR (2) BR112012019286A2 (pt)
CA (1) CA2807993C (pt)
CL (2) CL2013000430A1 (pt)
IL (3) IL224684A (pt)
MX (4) MX371047B (pt)
NZ (1) NZ606634A (pt)
PH (1) PH12016502498A1 (pt)
RU (2) RU2018108411A (pt)
SG (3) SG10202001032RA (pt)
UA (1) UA113616C2 (pt)
WO (1) WO2012021754A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1007885A2 (pt) 2009-02-03 2016-02-16 Microbion Corp bismuto-tóis antissépticos para tecidos epiteliais, feridas agudas e crônicas, biofilmes bacterianos e outras indicações
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
BR112012019286A2 (pt) * 2010-02-03 2018-06-26 Microbion Corp bismuto-tióis como antisséptico para usos biomédicos, que incluem tratamento de biofilmes bacterianos e outros usos
ES2647499T3 (es) * 2013-03-18 2017-12-21 Theranovis Gmbh & Co. Kg Composición para el cuidado bucal
RU2525200C1 (ru) * 2013-04-09 2014-08-10 Алексей Георгиевич Бородкин Средство для защиты и заживления ран деревьев
KR101703732B1 (ko) * 2013-11-07 2017-02-07 (주)아모레퍼시픽 효소처리 동백나무 씨 오일을 포함하는 항염 조성물
WO2017145142A1 (en) 2016-02-25 2017-08-31 Nobio Ltd. Micro and nanoparticulate compositions comprising anti-microbially active groups
CN116725879A (zh) 2017-08-30 2023-09-12 诺比奥有限公司 抗微生物颗粒及其使用方法
CN107950536A (zh) * 2017-12-04 2018-04-24 刘志伟 一种含百菌清的杀菌组合物
CN108839186B (zh) * 2018-05-15 2021-02-26 阜南县金威工艺品有限公司 一种桑枝编织品防霉处理方法
MX2021001276A (es) 2018-07-31 2021-07-15 Microbion Corp Composiciones de bismuto-tiol y metodos para tratar heridas.
EP3829307A4 (en) 2018-07-31 2022-08-03 Microbion Corporation BISMUTH-THIOL COMPOSITIONS AND METHODS OF USE
KR101990253B1 (ko) * 2018-11-22 2019-06-17 하봉호 컨테이너형 버섯재배장치
CN109997856B (zh) * 2019-04-15 2020-11-03 广西大学 一种小分子化合物的组合物及其应用
KR102126721B1 (ko) * 2019-07-16 2020-06-25 (주)인트론바이오테크놀로지 신규한 엔테로박터 애로진스 박테리오파지 Ent-AEP-1 및 이의 엔테로박터 애로진스 균과 엔테로박터 클로아카 균 증식 억제 용도
JP7458622B2 (ja) * 2019-09-18 2024-04-01 学校法人東京農業大学 抗生物質耐性微生物の耐性を低下させる物質及び抗生物質耐性微生物の耐性を低下させる方法
CN110663672B (zh) * 2019-11-13 2024-04-26 南京林业大学 一种螺纹驱动的根部施药头
US11479655B2 (en) * 2020-01-15 2022-10-25 The Boeing Company Compositions for use with polysulfide sealants and related methods
KR102197719B1 (ko) 2020-05-07 2021-01-04 곽태진 갑오징어 양식 시스템
CN111856546B (zh) * 2020-06-23 2022-07-29 中国辐射防护研究院 一种关于海洋生物灰中Cs-137放化分析的制样方法
CN113969300A (zh) * 2020-07-23 2022-01-25 启迪禾美生物科技(嘉兴)有限公司 一种桉树叶复合活性提取物工艺及其抗菌应用
CN112640907B (zh) * 2021-01-19 2021-11-16 西南大学 硫辛酸抑制植物真菌致病菌的新用途及防治柑橘果实采后真菌病害的方法
KR102431000B1 (ko) * 2021-07-22 2022-08-11 농업회사법인 주식회사 아그로비즈 아스피린과 벤조치아졸이 포함된 식물의 자가면역 증강제 조성물 및 이를 이용한 이용방법
EP4310192A1 (en) * 2022-07-21 2024-01-24 C4Diagnostics Method of determining the existence and/or degree of resistance of microorganisms to antimicrobial agents
CN115323778B (zh) * 2022-08-16 2023-07-18 汕头市润丰纺织科技实业有限公司 壳聚糖-i型胶原氨基酸复合抗菌整理液及其制备方法和抗菌面料
TR2022012983A2 (tr) * 2022-08-17 2022-09-21 Marmara Ueniv Strateji Gelis Dai Bsk Muhasebe Birimi Kemi̇k rahatsizliklari ve/veya kirilmalari i̇çi̇n onarici ve tedavi̇ edi̇ci̇ özelli̇kte bi̇youyumlu bi̇r ürün ve söz konusu ürünün eldesi̇ i̇çi̇n bi̇r yöntem
CN115532295B (zh) * 2022-09-27 2023-07-25 苏州大学 含有Zn-N-C活性中心的纳米材料在去除细菌生物膜中的应用
KR102644907B1 (ko) * 2023-12-01 2024-03-07 (주)신용이엔씨 지반 보강을 위한 친환경 그라우팅용 조성물 및 이의 제조 방법

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809971A (en) * 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
JP3813644B2 (ja) * 1994-08-29 2006-08-23 英治 安里 ビスマス錯体およびそれを含有する抗菌剤
US5928671A (en) * 1995-04-25 1999-07-27 Winthrop University Hospital Method and composition for inhibiting bacteria
US6086921A (en) * 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US6017936A (en) * 1997-03-14 2000-01-25 Arch Chemicals, Inc. Method for producing particles of pyrithione salts and particles so produced
US5999828A (en) * 1997-03-19 1999-12-07 Qualcomm Incorporated Multi-user wireless telephone having dual echo cancellers
AU2003204105B2 (en) * 1997-10-28 2005-11-17 Winthrop-University Hospital Metal/Thiol Biocides
AU2656799A (en) * 1998-02-04 1999-08-23 Winthrop-University Hospital Metal-thiols as imminomodulating agents
US6465015B1 (en) * 1998-02-24 2002-10-15 Arch Chemicals, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
TWI245763B (en) * 1998-04-02 2005-12-21 Janssen Pharmaceutica Nv Biocidal benzylbiphenyl derivatives
WO2000016623A1 (en) * 1998-09-23 2000-03-30 Phycogen, Inc. Antifouling agents
US6682724B2 (en) * 1999-02-23 2004-01-27 Arch Chemcials, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
US6630172B2 (en) * 2001-01-22 2003-10-07 Kareem I. Batarseh Microbicidal composition containing potassium sodium tartrate
US6582719B2 (en) * 2001-02-02 2003-06-24 The Trustees Of Columbia University In The City Of New York Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms
JP4357166B2 (ja) * 2002-10-21 2009-11-04 日揮触媒化成株式会社 抗菌・防黴・防藻性組成物
US7381751B2 (en) * 2003-08-26 2008-06-03 Shantha Sarangapani Antimicrobial composition for medical articles
KR101153785B1 (ko) * 2004-10-25 2012-07-09 셀로노바 바이오사이언시스 저머니 게엠베하 치료 및/또는 진단용으로 부가할 수 있는 중합체 입자 및이의 제조 및 사용 방법
JP4568232B2 (ja) * 2006-01-06 2010-10-27 秀和 西松 人工骨頭保持具
JP2007332040A (ja) * 2006-06-12 2007-12-27 Shinshu Univ カーボンナノチューブを含む抗菌剤とそれを用いた材料及び製剤
US20110008402A1 (en) * 2006-10-13 2011-01-13 Kane Biotech Inc. Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof
WO2008092011A2 (en) * 2007-01-24 2008-07-31 Cook Incorporated Biofilm-inhibiting medical products
US8343536B2 (en) * 2007-01-25 2013-01-01 Cook Biotech Incorporated Biofilm-inhibiting medical products
EP2154974A2 (en) * 2007-05-18 2010-02-24 AgION Technologies, Inc. Bioactive acid agrichemical compositions and use thereof
WO2008150375A1 (en) * 2007-06-01 2008-12-11 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
BRPI0721916A2 (pt) * 2007-07-25 2015-05-05 Celonova Biosciences Inc Partículas poliméricas codificadas por cor e dimensionadas para aplicações terapêuticas e/ou diagnósticas e métodos de preparação e uso das mesmas
BRPI1007885A2 (pt) * 2009-02-03 2016-02-16 Microbion Corp bismuto-tóis antissépticos para tecidos epiteliais, feridas agudas e crônicas, biofilmes bacterianos e outras indicações
BR112012019286A2 (pt) 2010-02-03 2018-06-26 Microbion Corp bismuto-tióis como antisséptico para usos biomédicos, que incluem tratamento de biofilmes bacterianos e outros usos

Also Published As

Publication number Publication date
CN103096720B (zh) 2016-03-30
AU2011289338A1 (en) 2013-03-28
JP2016117741A (ja) 2016-06-30
AU2011289338B2 (en) 2015-01-22
CA2807993A1 (en) 2012-02-16
KR101821833B1 (ko) 2018-01-25
KR20130000386A (ko) 2013-01-02
UA113616C2 (xx) 2017-02-27
CL2017002549A1 (es) 2018-05-11
MX362785B (es) 2019-02-12
EP2603083A2 (en) 2013-06-19
CN105766990B (zh) 2019-08-02
KR101966867B1 (ko) 2019-04-08
JP6685991B2 (ja) 2020-04-22
KR102074444B1 (ko) 2020-02-06
JP2020063277A (ja) 2020-04-23
JP2022003090A (ja) 2022-01-11
AU2018204190B2 (en) 2020-07-23
SG10201506131RA (en) 2015-09-29
KR20190039607A (ko) 2019-04-12
AU2016203475A1 (en) 2016-06-16
CL2013000430A1 (es) 2013-10-04
WO2012021754A3 (en) 2012-05-24
BR112012019286A2 (pt) 2018-06-26
CA2807993C (en) 2023-03-14
JP2018076358A (ja) 2018-05-17
JP2020055839A (ja) 2020-04-09
CN103096720A (zh) 2013-05-08
JP7097344B2 (ja) 2022-07-07
MX2019001293A (es) 2019-07-04
AU2018204190A1 (en) 2018-07-05
KR20130132410A (ko) 2013-12-04
SG187801A1 (en) 2013-03-28
RU2018108411A (ru) 2019-02-25
SG10202001032RA (en) 2020-04-29
NZ606634A (en) 2015-01-30
WO2012021754A2 (en) 2012-02-16
RU2013110493A (ru) 2014-09-20
IL258908A (en) 2018-06-28
JP2018008971A (ja) 2018-01-18
MX371047B (es) 2020-01-14
JP2013535506A (ja) 2013-09-12
MX2013001581A (es) 2013-03-20
CN105766990A (zh) 2016-07-20
JP6272366B2 (ja) 2018-01-31
IL224684A (en) 2016-11-30
MX2019010863A (es) 2019-11-05
IL248446B (en) 2018-05-31
PH12016502498A1 (en) 2018-06-11
KR20180085042A (ko) 2018-07-25
EP2603083A4 (en) 2014-10-22
KR20170136009A (ko) 2017-12-08
KR20200015814A (ko) 2020-02-12

Similar Documents

Publication Publication Date Title
BR112013003127A2 (pt) bismuto-tióis como antissépticos para usos agrícolas, industriais e outros
MX346409B (es) Tioles de bismuto como antisepticos para usos biomedicos, que incluyen tratamiento de biopeliculas bacterianas y otros usos.
BRPI0922220B8 (pt) uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos
WO2010091124A3 (en) Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
PH12019500360A1 (en) Antibiotic compounds
MX2011008043A (es) Derivados de actagardina.
BR112017007438A2 (pt) derivados bi aromáticos básicos antibacterianos com substituição de aminoalcoxi
BR112012021931A2 (pt) composto, composição farmacêutica, método para tratar uma infecção bacteriana, e, uso de composto
EA201270568A1 (ru) Антимикробные композиции и способы их получения и применения
BR112016016854A2 (pt) Derivados de 7-oxo-1,6-diazabiciclo[3.2.1]octana, seu processo de preparação e seu uso, composição farmacêutica e seu uso pedidos de patente relacionados
MX363478B (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
UA111210C2 (uk) Антибактеріальні 3,4-дигідро-1h-[1,8]нафтиридинони, заміщені циклопента[c]піролом
ZA202002093B (en) Antibacterial compounds
BR112015026193B8 (pt) Composição farmacêutica, método para formular uma composição farmacêutica, uso da composição farmacêutica, método para inibir a formação de biofilme em uma superfície, e, artigo fabricado para curativo
BR112012019565A2 (pt) formulações antimicrobianas com base em polissacarídeo
AR073917A1 (es) Sinergismo antibiotico
EA201590339A1 (ru) Новые антибактериальные соединения
CL2009000470A1 (es) Compuestos derivados de 6-oxo-2,3-dihidro-6h-1-oxa-3,3a-diaza-fenaleno sustituidos; procedimiento de preparacion de los compuestos; composicion farmaceutica; y su uso en el tratamiento de infecciones bacterianas, particularmente utiles frente a las bacterias gram (+) y a gram (-), como streptococcus, staphilococcus y escherichia coli, entre otras.
MX2009009074A (es) Macrolidos basados en eritromicina.
IL299751A (en) Preparations and methods for disinfection, treatment and prevention of bacterial infections
BR112012006250A2 (pt) composições e métodos para o tratamento de infecções bacterianas usando ceftaroline
WO2009124086A3 (en) Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections
BRPI1005541A2 (pt) associação farmacêutica fitoterápica, composição farmacêutica fitoterápica, processo de preparação de composição farmacêutica fitoterápica e seus usos veterinários
BR112018071101A2 (pt) derivados bioaromáticos antibacterianos com substituição de oxetana-3-iloxi

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A01N 55/02 (2006.01), A01N 59/02 (2006.01), A01P 1

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]